Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704
Titel:
Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704
Auteur:
LaFleur, F. Skillings, J. Hirsh, V. Bennouna, J. Kuo, H.-P. Szima, B. Gottfried, M. Kunitsyn, A. Trigo, J.M. Chang, G.-C. Cosaert, J. Reck, M.